China has administered over 31 million doses of COVID-19 vaccines
Share - WeChat
China has administered over 31 million doses of COVID-19 vaccines for key groups as of Wednesday.
China granted conditional market approval for its first COVID-19 vaccine on Dec 30, but vaccines in the last stage of clinical trials have been available for emergency use in the country since June. By the end of December, 14 COVID-19 vaccines developed by China were under clinical trials, including five in phase 3, the final trial before a vaccine is approved for market.
The inactivated COVID-19 vaccine, developed by State-owned Sinopharm, which won conditional market approval, is safe and has an efficacy of 79 percent, the company said.
- Shenzhou XVIII's post-1980 astronauts set for launch
- Beijing improves services to facilitate film and television projects
- Beijing man inherits properties after years of caring for elderly neighbor
- South China sees vast increase in precipitation
- Chang'e 7 to survey the lunar south pole in 2026
- Finland and Guangdong's Xuwen county forge dynamic sports partnership